Ontario Teachers Pension Plan Board Neurocrine Biosciences Inc Transaction History

Ontario Teachers Pension Plan Board

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$130.86 - $143.19 $343,769 - $376,160	2,627 Added 9.12%	31,439 $4.33 Million
Q1 2024 May 10, 2024	BUY	$130.4 - $143.74 $1.58 Million - $1.75 Million	12,149 Added 72.91%	28,812 $3.97 Million
Q4 2023 Feb 09, 2024	SELL	$106.07 - $132.76 $364,668 - $456,428	-3,438 Reduced 17.1%	16,663 $2.2 Million
Q3 2023 Nov 13, 2023	BUY	$94.02 - $117.1 $1.89 Million - $2.35 Million	20,101 New	20,101 $2.26 Million
Q2 2022 Aug 12, 2022	SELL	$75.79 - $100.07 $362,730 - $478,935	-4,786 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$72.45 - $94.81 $346,745 - $453,760	4,786 New	4,786 $449,000

627

94.3M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.2B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Ontario Teachers Pension Plan Board, based on Form 13F filings with the SEC.

Stay updated on Ontario Teachers Pension Plan Board with notifications on news.